← Leaderboards
Farah Babakhani
Optimer Pharmaceuticals, Inc.
$3,000,000
Attributed
$3,000,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2007–09$1M$750K$500K$250K$0
'07
'08
'09
Funding mix
By agency
NIH$3,000,000 · 1
By mechanism
R44$3,000,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Elderly”
- Charles A Coltman · Southwest Oncology Group$158,376,564
- Richard L Schilsky · University Of Chicago$122,071,723
- Michael W Weiner · Northern California Institute Res &Educ$99,760,701
- Monica M Bertagnolli · Strang Cancer Prevention Center$99,246,201
- Richard Mayeux · Columbia University Health Sciences$83,247,500
- Peter Gordon Gillespie · Oregon Health And Science University$80,983,248
Research focus
ElderlyEnsureDrug ResistanceEffectivenessBacteriaEnrollmentAftercareBacteroidesCanadaAntibioticsClinical Research SiteClinical TrialsCloningClostridium DifficileBactericideAncillary StudyDenaturing Gradient Gel ElectrophoresisDiarrheaDisadvantagedDisease OutbreaksCanis FamiliarisDna-Directed Rna PolymeraseDoseEnterococcus